Literature DB >> 20447748

CIP2A increases self-renewal and is linked to Myc in neural progenitor cells.

Laura Kerosuo1, Heli Fox, Nina Perälä, Kati Ahlqvist, Anu Suomalainen, Jukka Westermarck, Hannu Sariola, Kirmo Wartiovaara.   

Abstract

The oncogenic transcription factor Myc has an established role in the regulation of stem cell self-renewal and differentiation. However, the regulation of Myc activity or expression in stem and progenitor cells is not thoroughly understood. We studied the expression and function of the Myc stabilizing protein and a newly found oncogene, cancerous inhibitor of protein phosphatase 2A (CIP2A) in mouse neural progenitor cells (NPCs). We found intensive CIP2A expression in the neurogenic areas of the developing E13 as well as of the adult mouse brain. Here we also show that retroviral overexpression of CIP2A increases and siRNA silencing of CIP2A decreases NPC self-renewal and proliferation. Differentiation of the NPCs correlates with diminished CIP2A expression although overexpression of CIP2A does not prevent differentiation of neurons and astrocytes. Lastly, we demonstrate that both Myc and CIP2A enhance each other's expression and siRNA against CIP2A in Myc-overexpressing NPCs significantly reduces the ability of Myc to increase self-renewal and proliferation thus indicating a functional connection between CIP2A and Myc in NPCs. Copyright 2010 International Society of Differentiation. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20447748     DOI: 10.1016/j.diff.2010.04.003

Source DB:  PubMed          Journal:  Differentiation        ISSN: 0301-4681            Impact factor:   3.880


  16 in total

1.  Knockdown of CIP2A sensitizes ovarian cancer cells to cisplatin: an in vitro study.

Authors:  Xiaoli Zhang; Bin Xu; Chuanying Sun; Liming Wang; Xia Miao
Journal:  Int J Clin Exp Med       Date:  2015-09-15

2.  Cord blood-derived neuronal cells by ectopic expression of Sox2 and c-Myc.

Authors:  Alessandra Giorgetti; Maria C N Marchetto; Mo Li; Diana Yu; Raffaella Fazzina; Yangling Mu; Antonio Adamo; Ida Paramonov; Julio Castaño Cardoso; Montserrat Barragan Monasterio; Cedric Bardy; Riccardo Cassiani-Ingoni; Guang-Hui Liu; Fred H Gage; Juan Carlos Izpisua Belmonte
Journal:  Proc Natl Acad Sci U S A       Date:  2012-07-18       Impact factor: 11.205

3.  Enhanced expression of MycN/CIP2A drives neural crest toward a neural stem cell-like fate: Implications for priming of neuroblastoma.

Authors:  Laura Kerosuo; Pushpa Neppala; Jenny Hsin; Sofie Mohlin; Felipe Monteleone Vieceli; Zsofia Török; Anni Laine; Jukka Westermarck; Marianne E Bronner
Journal:  Proc Natl Acad Sci U S A       Date:  2018-07-18       Impact factor: 11.205

4.  Regulation of c-Myc Protein Abundance by a Protein Phosphatase 2A-Glycogen Synthase Kinase 3β-Negative Feedback Pathway.

Authors:  Lingfeng Liu; Robert N Eisenman
Journal:  Genes Cancer       Date:  2012-01

5.  Second generation tyrosine kinase inhibitors prevent disease progression in high-risk (high CIP2A) chronic myeloid leukaemia patients.

Authors:  C M Lucas; R J Harris; A K Holcroft; L J Scott; N Carmell; E McDonald; F Polydoros; R E Clark
Journal:  Leukemia       Date:  2015-03-13       Impact factor: 11.528

6.  p90/CIP2A mediates breast cancer cell proliferation and apoptosis.

Authors:  Xinxin Liu; Bo Peng; Yang Li; Ningjing Lei; Wenjie Li; Jian-Ying Zhang
Journal:  Mol Biol Rep       Date:  2014-08-03       Impact factor: 2.316

7.  Expression of CIP2A in renal cell carcinomas correlates with tumour invasion, metastasis and patients' survival.

Authors:  J Ren; W Li; L Yan; W Jiao; S Tian; D Li; Y Tang; G Gu; H Liu; Z Xu
Journal:  Br J Cancer       Date:  2011-11-10       Impact factor: 7.640

8.  Overexpression of CIP2A is an independent prognostic indicator in nasopharyngeal carcinoma and its depletion suppresses cell proliferation and tumor growth.

Authors:  Na Liu; Qing-Mei He; Jie-Wei Chen; Ying-Qin Li; Ya-Fei Xu; Xian-Yue Ren; Ying Sun; Hai-Qiang Mai; Jian-Yong Shao; Wei-Hua Jia; Tie-Bang Kang; Mu-Sheng Zeng; Jun Ma
Journal:  Mol Cancer       Date:  2014-05-19       Impact factor: 27.401

Review 9.  Oncogenic nexus of cancerous inhibitor of protein phosphatase 2A (CIP2A): an oncoprotein with many hands.

Authors:  Pradip De; Jennifer Carlson; Brian Leyland-Jones; Nandini Dey
Journal:  Oncotarget       Date:  2014-07-15

10.  Hexokinase-2-mediated aerobic glycolysis is integral to cerebellar neurogenesis and pathogenesis of medulloblastoma.

Authors:  Timothy R Gershon; Andrew J Crowther; Andrey Tikunov; Idoia Garcia; Ryan Annis; Hong Yuan; C Ryan Miller; Jeffrey Macdonald; James Olson; Mohanish Deshmukh
Journal:  Cancer Metab       Date:  2013-01-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.